Report Detail
Global Oncolytic Virus Therapy for Melanoma Market 2025 by Company, Regions, Type and Application, Forecast to 2031
- RnM4626845 |
- 26 September, 2025 |
- Global |
- 75 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Oncolytic Virus Therapy for Melanoma market size was valued at US$ 148 million in 2024 and is forecast to a readjusted size of USD 615 million by 2031 with a CAGR of 21.5% during review period.
Oncolytic virus therapy for melanoma is an innovative cancer treatment approach. Oncolytic viruses are either genetically engineered or naturally - occurring viruses that can selectively target and replicate within melanoma cells while minimizing damage to normal cells. These viruses have the ability to preferentially infect tumor cells because melanoma cells possess unique biological characteristics. For example, they have active cell - proliferation signaling pathways, defective antiviral immune responses, and certain specific cell - surface receptors. These features enable oncolytic viruses to more easily enter and replicate within melanoma cells.
This report is a detailed and comprehensive analysis for global Oncolytic Virus Therapy for Melanoma market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oncolytic Virus Therapy for Melanoma market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oncolytic Virus Therapy for Melanoma market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oncolytic Virus Therapy for Melanoma market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Oncolytic Virus Therapy for Melanoma market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncolytic Virus Therapy for Melanoma
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncolytic Virus Therapy for Melanoma market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Rigvir, Replimune (Pipeline), Takara Bio (Pipeline), Wuhan Binhui Biotechnology (Pipeline), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oncolytic Virus Therapy for Melanoma market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
HSV Virus
EHCO Virus
Others
Market segment by Application
Melanoma Treatment
Recurrence and Metastasis Prevention
Market segment by players, this report covers
Amgen
Rigvir
Replimune (Pipeline)
Takara Bio (Pipeline)
Wuhan Binhui Biotechnology (Pipeline)
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncolytic Virus Therapy for Melanoma product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus Therapy for Melanoma, with revenue, gross margin, and global market share of Oncolytic Virus Therapy for Melanoma from 2020 to 2025.
Chapter 3, the Oncolytic Virus Therapy for Melanoma competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oncolytic Virus Therapy for Melanoma market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus Therapy for Melanoma.
Chapter 13, to describe Oncolytic Virus Therapy for Melanoma research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Oncolytic Virus Therapy for Melanoma by Type
- 1.3.1 Overview: Global Oncolytic Virus Therapy for Melanoma Market Size by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Global Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type in 2024
- 1.3.3 HSV Virus
- 1.3.4 EHCO Virus
- 1.3.5 Others
- 1.4 Global Oncolytic Virus Therapy for Melanoma Market by Application
- 1.4.1 Overview: Global Oncolytic Virus Therapy for Melanoma Market Size by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Melanoma Treatment
- 1.4.3 Recurrence and Metastasis Prevention
- 1.5 Global Oncolytic Virus Therapy for Melanoma Market Size & Forecast
- 1.6 Global Oncolytic Virus Therapy for Melanoma Market Size and Forecast by Region
- 1.6.1 Global Oncolytic Virus Therapy for Melanoma Market Size by Region: 2020 VS 2024 VS 2031
- 1.6.2 Global Oncolytic Virus Therapy for Melanoma Market Size by Region, (2020-2031)
- 1.6.3 North America Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
- 1.6.4 Europe Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
- 1.6.5 Asia-Pacific Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
- 1.6.6 South America Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
- 1.6.7 Middle East & Africa Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
2 Company Profiles
- 2.1 Amgen
- 2.1.1 Amgen Details
- 2.1.2 Amgen Major Business
- 2.1.3 Amgen Oncolytic Virus Therapy for Melanoma Product and Solutions
- 2.1.4 Amgen Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Amgen Recent Developments and Future Plans
- 2.2 Rigvir
- 2.2.1 Rigvir Details
- 2.2.2 Rigvir Major Business
- 2.2.3 Rigvir Oncolytic Virus Therapy for Melanoma Product and Solutions
- 2.2.4 Rigvir Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Rigvir Recent Developments and Future Plans
- 2.3 Replimune (Pipeline)
- 2.3.1 Replimune (Pipeline) Details
- 2.3.2 Replimune (Pipeline) Major Business
- 2.3.3 Replimune (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
- 2.3.4 Replimune (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Replimune (Pipeline) Recent Developments and Future Plans
- 2.4 Takara Bio (Pipeline)
- 2.4.1 Takara Bio (Pipeline) Details
- 2.4.2 Takara Bio (Pipeline) Major Business
- 2.4.3 Takara Bio (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
- 2.4.4 Takara Bio (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Takara Bio (Pipeline) Recent Developments and Future Plans
- 2.5 Wuhan Binhui Biotechnology (Pipeline)
- 2.5.1 Wuhan Binhui Biotechnology (Pipeline) Details
- 2.5.2 Wuhan Binhui Biotechnology (Pipeline) Major Business
- 2.5.3 Wuhan Binhui Biotechnology (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
- 2.5.4 Wuhan Binhui Biotechnology (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Wuhan Binhui Biotechnology (Pipeline) Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Oncolytic Virus Therapy for Melanoma Revenue and Share by Players (2020-2025)
- 3.2 Market Share Analysis (2024)
- 3.2.1 Market Share of Oncolytic Virus Therapy for Melanoma by Company Revenue
- 3.2.2 Top 3 Oncolytic Virus Therapy for Melanoma Players Market Share in 2024
- 3.2.3 Top 6 Oncolytic Virus Therapy for Melanoma Players Market Share in 2024
- 3.3 Oncolytic Virus Therapy for Melanoma Market: Overall Company Footprint Analysis
- 3.3.1 Oncolytic Virus Therapy for Melanoma Market: Region Footprint
- 3.3.2 Oncolytic Virus Therapy for Melanoma Market: Company Product Type Footprint
- 3.3.3 Oncolytic Virus Therapy for Melanoma Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Oncolytic Virus Therapy for Melanoma Consumption Value and Market Share by Type (2020-2025)
- 4.2 Global Oncolytic Virus Therapy for Melanoma Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
- 5.1 Global Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application (2020-2025)
- 5.2 Global Oncolytic Virus Therapy for Melanoma Market Forecast by Application (2026-2031)
6 North America
- 6.1 North America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
- 6.2 North America Oncolytic Virus Therapy for Melanoma Market Size by Application (2020-2031)
- 6.3 North America Oncolytic Virus Therapy for Melanoma Market Size by Country
- 6.3.1 North America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2031)
- 6.3.2 United States Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 6.3.3 Canada Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 6.3.4 Mexico Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
7 Europe
- 7.1 Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
- 7.2 Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2031)
- 7.3 Europe Oncolytic Virus Therapy for Melanoma Market Size by Country
- 7.3.1 Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2031)
- 7.3.2 Germany Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 7.3.3 France Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 7.3.4 United Kingdom Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 7.3.5 Russia Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 7.3.6 Italy Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
8 Asia-Pacific
- 8.1 Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
- 8.2 Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2031)
- 8.3 Asia-Pacific Oncolytic Virus Therapy for Melanoma Market Size by Region
- 8.3.1 Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Region (2020-2031)
- 8.3.2 China Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 8.3.3 Japan Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 8.3.4 South Korea Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 8.3.5 India Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 8.3.6 Southeast Asia Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 8.3.7 Australia Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
9 South America
- 9.1 South America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
- 9.2 South America Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2031)
- 9.3 South America Oncolytic Virus Therapy for Melanoma Market Size by Country
- 9.3.1 South America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2031)
- 9.3.2 Brazil Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 9.3.3 Argentina Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
10 Middle East & Africa
- 10.1 Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
- 10.2 Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2031)
- 10.3 Middle East & Africa Oncolytic Virus Therapy for Melanoma Market Size by Country
- 10.3.1 Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2031)
- 10.3.2 Turkey Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 10.3.3 Saudi Arabia Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
- 10.3.4 UAE Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
11 Market Dynamics
- 11.1 Oncolytic Virus Therapy for Melanoma Market Drivers
- 11.2 Oncolytic Virus Therapy for Melanoma Market Restraints
- 11.3 Oncolytic Virus Therapy for Melanoma Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Oncolytic Virus Therapy for Melanoma Industry Chain
- 12.2 Oncolytic Virus Therapy for Melanoma Upstream Analysis
- 12.3 Oncolytic Virus Therapy for Melanoma Midstream Analysis
- 12.4 Oncolytic Virus Therapy for Melanoma Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Oncolytic Virus Therapy for Melanoma. Industry analysis & Market Report on Oncolytic Virus Therapy for Melanoma is a syndicated market report, published as Global Oncolytic Virus Therapy for Melanoma Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Oncolytic Virus Therapy for Melanoma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
